Anticoagulant Reversal Drugs Market Size, Share, Trends, Growth 2030
Anticoagulant Reversal Drugs Market By Product Type (Idarucizumab, Protamine, Prothrombin Complex Concentrates, Coagulation Factors, Phytonadione, Andexanet Alfa, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2030
Category: Chemical & Materials Report Format : PDF
Pages: 205 Report Code: ZMR-6104
Published Date: Feb-2023 Status : Published
| Market Size in 2021 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 0.83 Billion | USD 2.25 Billion | 11.27% | 2021 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Anticoagulant Reversal Drugs Market, (2022 - 2030) (US$ Billion)
- 2.2 Global Anticoagulant Reversal Drugs Market : snapshot
- Chapter 3. Global Anticoagulant Reversal Drugs Market - Industry Analysis
- 3.1 Anticoagulant Reversal Drugs Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Significant surge in cases of bleeding disorders and abnormal blood coagulation among people drives the market growth
- 3.3 Market Restraints
- 3.3.1. Extortionate cost of anticoagulant reversal drugs hinders the growth of the market
- 3.4 Market Opportunities
- 3.4.1. Increase in adoption of new technologies and development of novel medication offer remunerative opportunities for market growth
- 3.5 Market Challenges
- 3.5.1. Certain side effects linked with the application of drugs may act as a challenge to the growth of the market
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Anticoagulant Reversal Drugs Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Anticoagulant Reversal Drugs Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Anticoagulant Reversal Drugs Market - Product Type Analysis
- 5.1 Global Anticoagulant Reversal Drugs Market overview: By Product Type
- 5.1.1 Global Anticoagulant Reversal Drugs Market share, By Product Type, 2021 and 2030
- 5.2 Idarucizumab
- 5.2.1 Global Anticoagulant Reversal Drugs Market by Idarucizumab, 2022 - 2030 (US$ Billion)
- 5.3 Protamine
- 5.3.1 Global Anticoagulant Reversal Drugs Market by Protamine, 2022 - 2030 (US$ Billion)
- 5.4 Prothrombin Complex Concentrates
- 5.4.1 Global Anticoagulant Reversal Drugs Market by Prothrombin Complex Concentrates, 2022 - 2030 (US$ Billion)
- 5.5 Coagulation Factors
- 5.5.1 Global Anticoagulant Reversal Drugs Market by Coagulation Factors, 2022 - 2030 (US$ Billion)
- 5.6 Phytonadione
- 5.6.1 Global Anticoagulant Reversal Drugs Market by Phytonadione, 2022 - 2030 (US$ Billion)
- 5.7 Andexanet Alfa
- 5.7.1 Global Anticoagulant Reversal Drugs Market by Andexanet Alfa, 2022 - 2030 (US$ Billion)
- 5.8 Others
- 5.8.1 Global Anticoagulant Reversal Drugs Market by Others, 2022 - 2030 (US$ Billion)
- 5.1 Global Anticoagulant Reversal Drugs Market overview: By Product Type
- Chapter 6. Global Anticoagulant Reversal Drugs Market - Distribution Channel Analysis
- 6.1 Global Anticoagulant Reversal Drugs Market overview: By Distribution Channel
- 6.1.1 Global Anticoagulant Reversal Drugs Market share, By Distribution Channel, 2021 and 2030
- 6.2 Hospital Pharmacy
- 6.2.1 Global Anticoagulant Reversal Drugs Market by Hospital Pharmacy, 2022 - 2030 (US$ Billion)
- 6.3 Retail Pharmacy
- 6.3.1 Global Anticoagulant Reversal Drugs Market by Retail Pharmacy, 2022 - 2030 (US$ Billion)
- 6.4 Online Pharmacy
- 6.4.1 Global Anticoagulant Reversal Drugs Market by Online Pharmacy, 2022 - 2030 (US$ Billion)
- 6.1 Global Anticoagulant Reversal Drugs Market overview: By Distribution Channel
- Chapter 7. Anticoagulant Reversal Drugs Market - Regional Analysis
- 7.1 Global Anticoagulant Reversal Drugs Market Regional Overview
- 7.2 Global Anticoagulant Reversal Drugs Market Share, by Region, 2021 & 2030 (US$ Billion)
- 7.3. North America
- 7.3.1 North America Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.3.1.1 North America Anticoagulant Reversal Drugs Market, by Country, 2022 - 2030 (US$ Billion)
- 7.3.1 North America Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.4 North America Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030
- 7.4.1 North America Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030 (US$ Billion)
- 7.5 North America Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030
- 7.5.1 North America Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030 (US$ Billion)
- 7.4. Europe
- 7.4.2 Europe Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.4.2.1 Europe Anticoagulant Reversal Drugs Market, by Country, 2022 - 2030 (US$ Billion)
- 7.4.2 Europe Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.4 Europe Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030
- 7.4.1 Europe Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030 (US$ Billion)
- 7.5 Europe Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030
- 7.5.1 Europe Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030 (US$ Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.5.3.1 Asia Pacific Anticoagulant Reversal Drugs Market, by Country, 2022 - 2030 (US$ Billion)
- 7.5.3 Asia Pacific Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.4 Asia Pacific Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030
- 7.4.1 Asia Pacific Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030 (US$ Billion)
- 7.5 Asia Pacific Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030
- 7.5.1 Asia Pacific Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030 (US$ Billion)
- 7.6. Latin America
- 7.6.4 Latin America Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.6.4.1 Latin America Anticoagulant Reversal Drugs Market, by Country, 2022 - 2030 (US$ Billion)
- 7.6.4 Latin America Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.4 Latin America Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030
- 7.4.1 Latin America Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030 (US$ Billion)
- 7.5 Latin America Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030
- 7.5.1 Latin America Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030 (US$ Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.7.5.1 The Middle-East and Africa Anticoagulant Reversal Drugs Market, by Country, 2022 - 2030 (US$ Billion)
- 7.7.5 The Middle-East and Africa Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 7.4 The Middle-East and Africa Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030
- 7.4.1 The Middle-East and Africa Anticoagulant Reversal Drugs Market, by Product Type, 2022 - 2030 (US$ Billion)
- 7.5 The Middle-East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030
- 7.5.1 The Middle-East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel, 2022 - 2030 (US$ Billion)
- Chapter 8. Company Profiles
- 8.1 Pfizer Inc.
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 AstraZeneca
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Bristol-Myers Squibb Company
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Dr. Reddy's Laboratories Ltd
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Endo International plc
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Teva Pharmaceutical Industries Ltd
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Sun Pharmaceutical Industries Ltd
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Mylan N.V.
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Novartis AG
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Lupin
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Cipla Inc
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Aurobindo Pharma
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Sanofi
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 Merck & Co. Inc
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.15 Amneal Pharmaceuticals LLC.
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.16 Alvogen
- 8.16.1 Overview
- 8.16.2 Financials
- 8.16.3 Product Portfolio
- 8.16.4 Business Strategy
- 8.16.5 Recent Developments
- 8.17 Bausch Health Companies Inc.
- 8.17.1 Overview
- 8.17.2 Financials
- 8.17.3 Product Portfolio
- 8.17.4 Business Strategy
- 8.17.5 Recent Developments
- 8.1 Pfizer Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Anticoagulant Reversal Drugs Market attractiveness, By Product Type
- 6. Global Anticoagulant Reversal Drugs Market attractiveness, By Distribution Channel
- 7. Global Anticoagulant Reversal Drugs Market share by Product Type, 2022 and 2030 (US$ Billion)
- 8. Global Anticoagulant Reversal Drugs Market by Idarucizumab, 2022 - 2030 (US$ Billion)
- 9. Global Anticoagulant Reversal Drugs Market by Protamine, 2022 - 2030 (US$ Billion)
- 10. Global Anticoagulant Reversal Drugs Market by Prothrombin Complex Concentrates, 2022 - 2030 (US$ Billion)
- 11. Global Anticoagulant Reversal Drugs Market by Coagulation Factors, 2022 - 2030 (US$ Billion)
- 12. Global Anticoagulant Reversal Drugs Market by Phytonadione, 2022 - 2030 (US$ Billion)
- 13. Global Anticoagulant Reversal Drugs Market by Andexanet Alfa, 2022 - 2030 (US$ Billion)
- 14. Global Anticoagulant Reversal Drugs Market by Others, 2022 - 2030 (US$ Billion)
- 15. Global Anticoagulant Reversal Drugs Market share by Distribution Channel, 2022 and 2030 (US$ Billion)
- 16. Global Anticoagulant Reversal Drugs Market by Hospital Pharmacy, 2022 - 2030 (US$ Billion)
- 17. Global Anticoagulant Reversal Drugs Market by Retail Pharmacy, 2022 - 2030 (US$ Billion)
- 18. Global Anticoagulant Reversal Drugs Market by Online Pharmacy, 2022 - 2030 (US$ Billion)
- 19. Global Anticoagulant Reversal Drugs Market share, by Region, 2022 and 2030
- 20. North America Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 21. Europe Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 22. Asia Pacific Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 23. Latin America Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
- 24. The Middle-East and Africa Anticoagulant Reversal Drugs Market, 2022 - 2030 (US$ Billion)
Table Of Tables
- 1. Global Anticoagulant Reversal Drugs Market: Snapshot
- 2. Drivers of the Anticoagulant Reversal Drugs Market: impact analysis
- 3. North America Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 4. North America Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 5. U.S. Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 6. U.S. Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 7. Canada Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 8. Canada Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 9. Europe Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 10. Europe Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 11. Germany Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 12. Germany Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 13. France Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 14. France Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 15. U.K. Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 16. U.K. Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 17. Italy Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 18. Italy Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 19. Spain Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 20. Spain Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 21. Rest of Europe Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 22. Rest of Europe Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 23. Asia Pacific Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 24. Asia Pacific Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 25. China Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 26. China Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 27. Japan Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 28. Japan Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 29. India Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 30. India Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 31. South Korea Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 32. South Korea Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 33. South-East Asia Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 34. South-East Asia Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 35. Rest of Asia Pacific Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 36. Rest of Asia Pacific Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 37. Latin America Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 38. Latin America Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 39. Brazil Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 40. Brazil Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 41. Mexico Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 42. Mexico Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 43. Rest of Latin America Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 44. Rest of Latin America Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 45. The Middle-East and Africa Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 46. The Middle-East and Africa Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 47. GCC Countries Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 48. GCC Countries Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 49. South Africa Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 50. South Africa Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
- 51. Rest of Middle-East Africa Anticoagulant Reversal Drugs Market revenue, By Product Type, 2022 - 2030 (US$ Billion)
- 52. Rest of Middle-East Africa Anticoagulant Reversal Drugs Market revenue, By Distribution Channel, 2022 - 2030 (US$ Billion)
Methodology
FrequentlyAsked Questions
The major factors influencing the growth of global anticoagulant reversal drugs include an increase in the cases of bleeding disorders and abnormal blood coagulation among people, an increase in the cases of heart attacks, and a rise in R&D activities for effective drug discovery and drug testing procedures drive the growth of the market.
According to the report, the global anticoagulant reversal drugs market was worth around US$ 0.83 Billion in 2021 and is projected to grow around USD 2.25 Billion by 2030, with a compounded annual growth rate (CAGR) of roughly 11.27% from 2022 to 2030.
The global anticoagulant reversal drugs market is expected to be driven by the North American region. The major reason for the growth of the market in this region is the rise in the geriatric population, favorable approval of drugs, and the prevalence of proper healthcare infrastructure by eminent players in the market.
The major players of the global anticoagulant reversal drugs market include Pfizer Inc., AstraZeneca, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd, Endo International plc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., Novartis AG, Lupin, Cipla Inc, Aurobindo Pharma, Sanofi, Merck & Co., Inc, Amneal Pharmaceuticals LLC., Alvogen, Bausch Health Companies Inc., among other global players.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed